NAKAGAWA Shunsuke 中川俊輔

… Alternative Names

Nakagawa Shunsuke 中川俊輔

中川俊輔ナカガワシュンスケ

Less

Researcher Number	60789973
Affiliation (Current)	2026: 鹿児島大学, 医歯学域医学系, 助教
Affiliation (based on the past Project Information) *help	2023 – 2025: 鹿児島大学, 医歯学域医学系, 助教 2020 – 2024: 鹿児島大学, 鹿児島大学病院, 医員 2021 – 2023: 鹿児島大学, 医歯学総合研究科, 特任助教 2018: 鹿児島大学, 附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 52050:Embryonic medicine and pediatrics-related / Basic Section 50010:Tumor biology-related Except Principal Investigator Basic Section 52050:Embryonic medicine and pediatrics-related
Keywords	Principal Investigator 小児白血病 / 核小体ストレス応答 / P53 / 薬剤耐性 / 小児急性リンパ性白血病 / 抗腫瘍薬多剤耐性 / 免疫染色 / メチル化 / 画像解析 / RPL11 … More / 多剤耐性 / 薬剤抵抗性 / p53 / 治療抵抗性 … More Except Principal Investigator 核小体ストレス応答 / カルシウムイオン / アルデヒド脱水素酵素 / 造血細胞移植 / アクロレイン / 心筋障害 / シクロフォスファミド / ALL / 小児 / フェロトーシス / アスパラギナーゼ / 標識プローブ化合物 / 標的タンパク質 / がん分子標的治療薬 / 画像解析 / RPL11モノクローナル抗体 / 薬剤感受性予測診断 / 感受性マーカー / 小児白血病 / p53経路 / ABL1変異 / SIRT1 / Ph+ALL / 治療 / 内皮細胞 / COX-2阻害薬 / リンパ管奇形 Less

Development of a therapy to overcome treatment-resistant leukemia by inducing reactivation of the nucleolar stress responsePrincipal Investigator
- Principal Investigator
  
  中川俊輔
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
Prevention of cyclophosphamide induced myocardial damage by avoiding calcium ion dysregulation..
- Principal Investigator
  
  西川拓朗
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
個別化医療を目指したP53を制御する新たな機構を利用した小児白血病の分子標的治療薬
- Principal Investigator
  
  河原康一
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
L-アスパラギナーゼの核小体ストレス応答を介した新たな抗がん作用の解明
- Principal Investigator
  
  中村達郎
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
Development of a New Childhood Leukemia Therapy Using Nucleolar Stress Response to Release Anticancer Drug ResistancePrincipal Investigator
- Principal Investigator
  
  Nakagawa Shunsuke
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
Ph＋ALL細胞におけるSIRT1が誘導するABL1変異獲得の機序の解明
- Principal Investigator
  
  児玉祐一
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
Development of a new treatment for lymphatic malformations with COX-2 inhibitors
- Principal Investigator
  
  Okamoto Yasuhiro
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
Development of Innovative Childhood Leukemia Therapy Using the Nucleolar Stress ResponsePrincipal Investigator
- Principal Investigator
  
  Nakagawa Shunsuke
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Kagoshima University
p53を制御する新たな機構を利用した小児白血病の新規治療戦略Principal Investigator
- Principal Investigator
  
  中川俊輔
- Project Period (FY)
  2018
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kagoshima University

All 2025 2024 2023 2022 2021

All Journal Article Presentation Patent

[Journal Article] Perspectives in newborn screening for SCID in Japan. Case report: newborn screening identified X-linked severe combined immunodeficiency with a novel IL2RG variant2024
- Author(s)
  Beppu Shiro、Nishikawa Takuro、Tomomasa Dan、Hijikata Atsushi、Kasabata Hiroshi、Terazono Hideyuki、Ikawa Kazuro、Nakamura Tatsuro、Horikawa Shogo、Nagahama Jun、Nakamura Aki、Abematsu Takanari、Nakagawa Shunsuke、Oketani Kaoru、Kanegane Hirokazu、Okamoto Yasuhiro
- Journal Title
  
  Frontiers in Immunology
  
  Volume: 15 Pages: 1478411-1478411
- DOI
  10.3389/fimmu.2024.1478411
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07887, KAKENHI-PROJECT-22K12250, KAKENHI-PROJECT-24K11003
[Journal Article] Blinatumomab Maintenance Therapy Following Bone Marrow Transplantation for Early Relapsed Pediatric B-cell Precursor Acute Lymphoblastic Leukemia and Analysis of Lymphocyte Subset Changes2024
- Author(s)
  Abematsu Takanari、Nishikawa Takuro、Kasabata Hiroshi、Nakagawa Shunsuke、Okamoto Yasuhiro
- Journal Title
  
  Cureus
  
  Volume: 12 Pages: 62263-62263
- DOI
  10.7759/cureus.62263
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24K11003
[Journal Article] Spontaneous remission in a case of neonatal leukemia with <i>KMT2A</i> gene rearrangement2024
- Author(s)
  Yasudome Yuki、Nakagawa Shunsuke、Nagahama Jun、Nakamura Tatsuro、Abematsu Takanari、Kodama Yuichi、Nishikawa Takuro、Okamoto Yasuhiro
- Journal Title
  
  Pediatric Blood & Cancer
  
  Volume: 71 Issue: 10 Pages: 31235-31235
- DOI
  10.1002/pbc.31235
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24K11003
[Journal Article] Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia2023
- Author(s)
  Nagahama Jun、Nishikawa Takuro、Nakamura Tatsuro、Nakagawa Shunsuke、Kodama Yuichi、Terazono Hideyuki、Wakamatsu Manabu、Muramatsu Hideki、Yamashiro Yasuhiro、Kanno Hitoshi、Okamoto Yasuhiro
- Journal Title
  
  Pediatric Blood & Cancer
  
  Volume: 70 Issue: 12
- DOI
  10.1002/pbc.30706
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07851
[Journal Article] Epidural cerebrospinal fluid leak with neurologic abnormalities after intrathecal therapy in a female with acute lymphoblastic leukemia2023
- Author(s)
  Matsumura Yuka、Nakamura Tatsuro、Nagahama Jun、Yasudome Yuki、Abematsu Takanari、Nakagawa Shunsuke、Yonee Chihiro、Kodama Yuichi、Nishikawa Takuro、Okamoto Yasuhiro
- Journal Title
  
  Pediatric Blood & Cancer
  
  Volume: 71 Issue: 1
- DOI
  10.1002/pbc.30715
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07851
[Journal Article] Changes in intracellular activation-related gene expression and induction of Akt contribute to acquired resistance toward nelarabine in CCRF-CEM cell line2022
- Author(s)
  Rindiarti A, Okamoto Y, Nakagawa S, Hirose J, Kodama Y, Nishikawa T, Kawano Y.
- Journal Title
  
  Leuk Lymphoma.
  
  Volume: 63 Issue: 2 Pages: 404-415
- DOI
  10.1080/10428194.2021.1992617
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08232, KAKENHI-PROJECT-21K07851
[Journal Article] Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood treated with the ICE regimen and allogeneic hematopoietic stem-cell transplantation.2022
- Author(s)
  [Jun Nagahama,Takuro Nishikawa,Takashi Tasaki,Yuki Yasudome,Tatsuro Nakamura,Takanari Abematsu,Shunsuke Nakagawa,Yuichi Kodama,Akihide Tanimoto,Yasuhiro Okamoto]
- Journal Title
  
  Pediatric blood & cancer
  
  Volume: 70 Issue: 3
- DOI
  10.1002/pbc.30041
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07851, KAKENHI-PROJECT-20K08232
[Journal Article] Pediatric acute myeloid leukemia co-expressing FLT3/ITD and NUP98/NSD1 treated with gilteritinib plus allogenic peripheral blood stem cell transplantation: A case report2021
- Author(s)
  Abematsu T, Nishikawa T, Shiba N, Iijima-Yamashita Y, Inaba Y, Takahashi Y, Nakagawa S, Kodama Y, Okamoto Y, Kawano Y.
- Journal Title
  
  Pediatr Blood Cancer.
  
  Volume: 68 Issue: 11
- DOI
  10.1002/pbc.29216
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08232, KAKENHI-PROJECT-21K07851
[Patent] 画像処理方法及びプログラム2025
- Inventor(s)
  河原康一、中川俊輔、藤井里紗、岡本康裕、有馬一成、安木千央
- Industrial Property Rights Holder
  鹿児島大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2025-017874
- Filing Date
  2025
- Data Source
  KAKENHI-PROJECT-23K07296
[Patent] 小児白血病に対する薬剤の有効性の判定を補助する方法，小児白血病に対する薬剤投与後の予後の判定を補助する方法及びキット2021
- Inventor(s)
  中川俊輔，河原康一，古川龍彦，岡本康裕
- Industrial Property Rights Holder
  中川俊輔，河原康一，古川龍彦，岡本康裕
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-070943
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-20K16929
[Patent] 小児白血病に対する薬剤の有効性の判定を補助する方法、小児白血病に対する薬剤投与後の予後の判定を補助する方法及びキット2021
- Inventor(s)
  中川俊輔，河原康一，岡本康裕，古川龍彦
- Industrial Property Rights Holder
  国立大学法人鹿児島大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-070943
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-20K16929
[Presentation] 癌抑制因子p53を制御する機構による小児腫瘍の治療感受性の検討2025
- Author(s)
  山下恵汰,有馬一成, 安木千央,中川俊輔,岡本康裕,古川龍彦,河原康一
- Organizer
  日本薬学会第145年会
- Data Source
  KAKENHI-PROJECT-23K07296
[Presentation] 12誘導心電図を用いたシクロホスファミド心筋障害早期発見の有用性2025
- Author(s)
  長濱　潤，川村順平，西川拓朗，堀川翔伍，中村達郎，棈松貴成，中川俊輔，岡本康裕
- Organizer
  日本造血・免疫細胞療法学会総会
- Data Source
  KAKENHI-PROJECT-24K11003
[Presentation] 小児急性リンパ性白血病の造血幹細胞移植症例におけるVVT1値推移の解析2024
- Author(s)
  棈松貴成，西川拓朗，長濱　潤，安留悠希，中村達郎，中川俊輔，児玉祐一，岡本康裕
- Organizer
  日本造血・免疫細胞療法学会総会
- Data Source
  KAKENHI-PROJECT-24K11003
[Presentation] 小児腫瘍の抗癌剤治療感受性に影響する核小体ストレス応答機構の役割の解析2024
- Author(s)
  山下恵汰,有馬一成, 安木千央,中川俊輔,岡本康裕,古川龍彦,河原康一
- Organizer
  令和6年度日本生化学会九州支部例会
- Data Source
  KAKENHI-PROJECT-23K07296
[Presentation] 核小体ストレス応答によるp53経路の活性と小児固形腫瘍に対する抗癌剤治療の感受性への影響2024
- Author(s)
  山下恵汰,有馬一成,安木千央,中川俊輔,岡本康裕,古川龍彦,河原康一
- Organizer
  第47回日本分子生物学会年会
- Data Source
  KAKENHI-PROJECT-23K07296
[Presentation] Nucleolar stress response predicts sensitivity to anticancer therapy2023
- Author(s)
  Kohichi Kawahara, Shunsuke Nakagawa, Yasuhiro Okamoto, Tatsuhiko Furukawa
- Organizer
  10th MDM2 workshop
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K07296
[Presentation] Nucleolar stress response predicts sensitivity to anticancer therapy2023
- Author(s)
  Kohichi Kawahara, Shunsuke Nakagawa, Yasuhiro Okamoto, Tatsuhiko Furukawa
- Organizer
  ANNUAL CONGRESS OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K07296
[Presentation] Association between Dysfunction of the Nucleolar Stress Response and Multidrug Resistance in Pediatric Acute Lymphoblastic Leukemia2023
- Author(s)
  Shunsuke Nakagawa, Takuro Nishikawa, Kohichi Kawahara, Yasuhiro Okamoto
- Organizer
  10th MDM2 workshop
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K07296

1. Okamoto Yasuhiro (30398002)

# of Collaborated Projects: 7 results

# of Collaborated Products: 15 results
2. 西川拓朗 (90535725)

# of Collaborated Projects: 3 results

# of Collaborated Products: 9 results
3. 河原康一 (00400482)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
4. 児玉祐一 (20535695)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
5. 中村達郎 (50902269)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
6. KAWANO Yoshifumi

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
7. 金兼弘和

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

NAKAGAWA Shunsuke 中川 俊輔

Nakagawa Shunsuke 中川 俊輔

中川 俊輔 ナカガワ シュンスケ

Research Projects

Research Products

Co-Researchers

Development of a therapy to overcome treatment-resistant leukemia by inducing reactivation of the nucleolar stress responsePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Prevention of cyclophosphamide induced myocardial damage by avoiding calcium ion dysregulation..

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

個別化医療を目指したP53を制御する新たな機構を利用した小児白血病の分子標的治療薬

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

L-アスパラギナーゼの核小体ストレス応答を介した新たな抗がん作用の解明

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a New Childhood Leukemia Therapy Using Nucleolar Stress Response to Release Anticancer Drug ResistancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Ph＋ALL細胞におけるSIRT1が誘導するABL1変異獲得の機序の解明

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new treatment for lymphatic malformations with COX-2 inhibitors

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Innovative Childhood Leukemia Therapy Using the Nucleolar Stress ResponsePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

p53を制御する新たな機構を利用した小児白血病の新規治療戦略Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Perspectives in newborn screening for SCID in Japan. Case report: newborn screening identified X-linked severe combined immunodeficiency with a novel IL2RG variant2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Blinatumomab Maintenance Therapy Following Bone Marrow Transplantation for Early Relapsed Pediatric B-cell Precursor Acute Lymphoblastic Leukemia and Analysis of Lymphocyte Subset Changes2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Spontaneous remission in a case of neonatal leukemia with <i>KMT2A</i> gene rearrangement2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia2023

Author(s)

Journal Title

DOI

Data Source

NAKAGAWA Shunsuke 中川俊輔

Nakagawa Shunsuke 中川俊輔

中川俊輔ナカガワシュンスケ